Showing results 1 to 20 of 43
next >
| Issue Date | Title | Author(s) |
| 16-Nov-2015 | Anti-Pseudomonal Bacteriophage Reduces Infective Burden and Inflammatory Response in Murine Lung | Pabary, R; Singh, C; Morales, S; Bush, A; Alshafi, K, et al |
| 19-Apr-2021 | Bacteriophage infection of Escherichia coli leads to the formation of membrane vesicles via both explosive cell lysis and membrane blebbing | Mandal, PK; Ballerin, G; Nolan, LM; Petty, NK; Whitchurch, CB, et al |
| 1-Jan-2020 | Cephalosporin nitric oxide-donor prodrug DEA-C3D disperses biofilms formed by clinical cystic fibrosis isolates of Pseudomonas aeruginosa | Soren, O; Rineh, A; Silva, DG; Cai, Y; Howlin, RP, et al |
| 4-Apr-2021 | CF fungal disease in the age of CFTR modulators | Bercusson, A; Jarvis, G; Shah, A; |
| 1-Jul-2020 | ChpC controls twitching motility-mediated expansion of Pseudomonas aeruginosa biofilms in response to serum albumin, mucin and oligopeptides | Nolan, LM; McCaughey, LC; Merjane, J; Turnbull, L; Whitchurch, CB, et al |
| 6-Apr-2021 | Colistin kills bacteria by targeting lipopolysaccharide in the cytoplasmic membrane | Sabnis, A; Haggard, K; Kloeckner, A; Becce, M; Evans, L, et al |
| 1-Oct-2020 | Confronting and mitigating the risk of COVID-19 Associated Pulmonary Aspergillosis (CAPA) | Armstrong-James, D; Youngs, J; Bicanic, T; Abdolrasouli, A; Denning, DW, et al |
| 31-Aug-2016 | Cystic fibrosis gene therapy: a mutation-independent treatment | Griesenbach, U; Davies, JC; Alton, E; , et al |
| 25-Aug-2021 | Device design modifications informed by in vitro testing of bacterial attachment reduce infection rates of cochlear implants in clinical practice | Turnbull, L; Leigh, R; Cavaliere, R; Osvath, SR; Nolan, L, et al |
| Feb-2020 | Early growth in cystic fibrosis and the pathways to lung function | Jarvis, Deborah; Macdougall, Amy Meryl; |
| Aug-2022 | Environmental influences on the pulmonary manifestations of Cystic Fibrosis | Piel, Frederic; Cullinan, Paul; Murrin, Olivia; |
| 1-Nov-2015 | Ex Vivo and In Vivo Lentivirus-Mediated Transduction of Airway Epithelial Progenitor Cells. | Leoni, G; Wasowicz, MY; Chan, M; Meng, C; Farley, R, et al |
| 20-Mar-2021 | Fungal-induced programmed cell death | Williams, TJ; Gonzales-Huerta, LE; Armstrong-James, D; , et al |
| 6-May-2016 | Gene therapy for cystic fibrosis: recent progress and current aims | Paul-Smith, MC; Bell, RV; Alton, WE; Alton, EWFW; Griesenbach, U, et al |
| 1-Jul-2019 | Health economic modelling in Cystic Fibrosis: a systematic review | Mohindru, B; Turner, D; Sach, T; Bilton, D; Carr, S, et al |
| 1-Mar-2020 | Health state utility data in cystic fibrosis: a systematic review | Mohindru, B; Turner, D; Sach, T; Bilton, D; Carr, S, et al |
| 11-Apr-2019 | Impact of cystic fibrosis on birthweight: a population based study of children in Denmark and Wales | Schlüter, DK; Griffiths, R; Adam, A; Akbari, A; Heaven, ML, et al |
| 15-Jun-2018 | Impact of T2R38 receptor polymorphisms on pseudomonas aeruginosa infection in cystic fibrosis | Turnbull, AR; Murphy, R; Behrends, V; Lund-Palau, H; Simbo, A, et al |
| 1-Mar-2022 | Incidence and risk factors of cancer in individuals with cystic fibrosis in the UK; a case-control study. | Archangelidi, O; Cullinan, P; Simmonds, NJ; Mentzakis, E; Peckham, D, et al |
| 7-Apr-2017 | Intravascular donor monocytes play a central role in lung transplant ischaemia-reperfusion injury | Tatham, KC; O'Dea, KP; Romano, R; Donaldson, HE; Wakabayashi, K, et al |